A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Clinical trial NCT07615426 · RECRUITING
Trial details
- NCT number
- NCT07615426
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-02
- Primary completion
- 2027-06-21
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.